| [1] |
Trifirò G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study[J]. Ann Rheum Dis, 2013, 72(5): 694-700.
doi: 10.1136/annrheumdis-2011-201254
URL
|
| [2] |
Liu R, Han C, Wu D, et al. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis[J]. Biomed Res Int, 2015, 2015: 762820.
|
| [3] |
Liu J, Shen P, Ma X, et al. White blood cell count and the incidence of hyperuricemia: insights from a community-based study[J]. Front Med, 2019, 13(6): 741-746.
doi: 10.1007/s11684-017-0579-7
URL
|
| [4] |
Gharipour M, Ramezani MA, Sadeghi M, et al. Sex based levels of C-reactive protein and white blood cell count in subjects with metabolic syndrome[J]. J Res Med Sci, 2013, 18(6): 467-472.
pmid: 24250693
|
| [5] |
中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊断标准[J]. 中华肝脏病杂志, 2003, 11(27): 71.
|
| [6] |
Wang H, Wang L, Xie R, et al. Association of serum uric acid with body mass index: a cross-sectional study from Jiangsu province, China[J]. Iran J Public Health, 2014, 43(11): 1503-1509.
|
| [7] |
Hou YL, Yang XL, Wang CX, et al. Hypertriglyceridemia and hyperuricemia: a retrospective study of urban residents[J]. Lipids Health Dis, 2019, 18(1): 81.
doi: 10.1186/s12944-019-1031-6
pmid: 30935401
|
| [8] |
Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes[J]. Diabetes Care, 2009, 32(9): 1737-1742.
doi: 10.2337/dc09-0288
URL
|
| [9] |
Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992[J]. JAMA, 2000, 283(18): 2404-2410.
doi: 10.1001/jama.283.18.2404
URL
|
| [10] |
Li M, Hu X, Fan Y, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis[J]. Sci Rep, 2016, 6: 19520.
doi: 10.1038/srep19520
URL
|
| [11] |
中国医师协会心血管内科医师分会. 无症状高尿酸血症合并心血管疾病诊治建议中国专家共识[J]. 中国临床医生杂志, 2011, (2): 73-77.
|
| [12] |
Marsoni S, Damia G. Molecular targeting: new therapeutic strategies to improve tumour apoptosis[J]. Ann Oncol, 2004, 15 Suppl 4: 229-231.
doi: 10.1093/oxfordjournals.annonc.a058462
URL
|
| [13] |
Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers[J]. Eur Heart J, 2006, 27(10): 1174-1181.
doi: 10.1093/eurheartj/ehi879
URL
|
| [14] |
Kocaman SA, Sahinarslan A, Cemri M, et al. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden[J]. Nutr Metab Cardiovasc Dis, 2009, 19(10): 729-735.
doi: 10.1016/j.numecd.2008.12.010
pmid: 19699626
|
| [15] |
Facchini F, Chen YD, Hollenbeck CB, et al. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration[J]. JAMA, 1991, 266(21): 3008-3011.
doi: 10.1001/jama.1991.03470210076036
URL
|
| [16] |
Chen H, Ding X, Li J, et al. White blood cell count: an independent predictor of coronary heart disease risk in middle-aged and elderly population with hyperuricemia[J]. Medicine (Baltimore), 2018, 97(51): e13729.
doi: 10.1097/MD.0000000000013729
URL
|
| [17] |
Gillum RF, Mussolino ME, Madans JH. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-Ⅰ epidemiologic follow-up study[J]. Ann Epidemiol, 2005, 15(4): 266-271.
pmid: 15780773
|
